Mathieu Quesnel-Vallières

12PUBLICATIONS
51CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMetabolic medicineEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 27, 2025
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas.

Priyanka Sehgal, Ammar S Naqvi, Makenna Higgins

|Aug 02, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.

Manuel Torres-Diz, Clara Reglero, Catherine D Falkenstein

|Aug 02, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.

Manuel Torres-Diz, Clara Reglero, Catherine D Falkenstein

|May 07, 2024
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies.

Xiaolei Liu, Sudhish A Devadiga, Robert F Stanley

|Nov 12, 2023
MAJIQlopedia: an encyclopedia of RNA splicing variations in human tissues and cancer.

Mathieu Quesnel-Vallières, San Jewell, Kristen W Lynch

|Jan 04, 2023
A Bayesian model for unsupervised detection of RNA splicing based subtypes in cancers.

David Wang, Mathieu Quesnel-Vallieres, San Jewell

Pageof 2

Frequent Collaborators

7 joint publications

Yoseph Barash

5 joint publications

Andrei Thomas-Tikhonenko

2 joint publications

Caleb M Radens

2 joint publications

Adolfo Ferrando